Regulatory press release

H100 Group Announces Triggering of Tranches 2–4 and Immediate Conversion of Tranches 1–4 Under Convertible Loan Framework

H100 Group AB (publ) (“H100 Group” or the “Company”) has today received notification from Adam Back and Eagles Rising AB that they will exercise their right to invest in Tranche 2, 3 and 4 under the Company’s convertible loan framework, as announced on 3 June and 9 June 2025.

Simultaneously, the Company has received notices from both investors requesting that the full loan amounts under Tranches 1, 2, 3 and 4 shall be converted into shares in the Company in accordance with the terms in the investment and loan agreements. The agreed conversion prices are SEK 1.75 per share for Tranche 1, SEK 2.28 for Tranche 2, SEK 2.96 for Tranche 3, and SEK 3.84 for Tranche 4.

Under these terms, Adam Back has been allocated SEK 15.5 million in Tranche 1 and will be allocated SEK 15.75 million in Tranche 2, SEK 23.625 million in Tranche 3, and SEK 35.437 million in Tranche 4, amounting to a total loan contribution of approximately SEK 90.3 million. Eagles Rising AB has been allocated SEK 5.775 million in Tranche 1 and will be allocated SEK 11.025 million in Tranche 2, SEK 16.537 million in Tranche 3, and SEK 24.806 million in Tranche 4, for a total of approximately SEK 58.1 million. This implies a further capital commitment to the Company of SEK 127.1 million in addition to the SEK 101 million as announced yesterday.

Additionally, the Company has received a conversion notice from Adam Back regarding the SEK 13.5 million convertible loan announced on 25 May 2025.

The Board of Directors intends to resolve on the necessary share issues in order to effectuate the conversion, by virtue of the authorization granted by the Extraordinary General Meeting on 7 March 2025, as soon as possible. A separate press release will be issued upon resolution.

THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, CANADA, HONG KONG, BELARUS, RUSSIA OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLISHING OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW. SEE SECTION "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE.

About H100 Group

H100 Group AB is a health technology company operating in the health and longevity industry. The company’s business idea is to support providers of health and lifestyle services through AI-powered automation, digital growth tools, and integrated platform solutions, with the goal of helping people live healthy lives to 100 and beyond.
H100 follows a clear growth strategy focused on building a seamless ecosystem where AI integration enhances efficiency and expands service offerings. Growth is further accelerated through strategic acquisitions of key players within its ecosystem, aiming to consolidate and scale the business.
The company is listed on NGM Nordic SME. For more information, visit www.h100.group.